Moscovich M, Okun Michael S, Favilla Chris, Figueroa Karla P, Pulst Stefan M, Perlman Susan, Wilmot George, Gomez Christopher, Schmahmann Jeremy, Paulson Henry, Shakkottai Vikram, Ying Sarah, Zesiewicz Theresa, Kuo S H, Mazzoni P, Bushara Khalaf, Xia Guangbin, Ashizawa Tetsuo, Subramony S H
Department of Neurology (MM, MSO, CF, GX, TA, SHS), McKnight Brain Institute, University of Florida, Gainesville, Florida; Department of Neurology (KPF, SMP), University of Utah, Salt Lake City, Utah; Department of Neurology (SP), University of California, Los Angeles, Los Angeles, California; Department of Neurology (GW), Emory University, Atlanta, Georgia; Department of Neurology (CG), University of Chicago, Chicago, Illinois; Department of Neurology (JS), Massachusetts General Hospital, Harvard Medical School; Department of Neurology (HP, VS), University of Michigan, Ann Arbor, Michigan; Department of Neurology (SY), Johns Hopkins University, Baltimore, Maryland; Department of Neurology (TZ), University of South Florida, Tampa, Florida; Department of Neurology (SHK, PM), Columbia University, New York, New York; and Department of Neurology (KB), University of Minnesota, Minneapolis, Minnesota.
J Neuroophthalmol. 2015 Mar;35(1):16-21. doi: 10.1097/WNO.0000000000000167.
Ocular motor abnormalities reflect the varied neuropathology of spinocerebellar ataxias (SCAs) and may serve to clinically distinguish the different SCAs. We analyzed the various eye movement abnormalities detected prospectively at the baseline visit during a large multicenter natural history study of SCAs 1, 2, 3, and 6.
The data were prospectively collected from 12 centers in the United States in patients with SCAs 1, 2, 3, and 6, as part of the Clinical Research Consortium for Spinocerebellar Ataxias (NIH-CRC-SCA). Patient characteristics, ataxia rating scales, the Unified Huntington Disease Rating Scale functional examination, and clinical staging were used. Eye movement abnormalities including nystagmus, disorders of saccades and pursuit, and ophthalmoparesis were recorded, and factors influencing their occurrence were examined.
A total of 301 patients participated in this study, including 52 patients with SCA 1, 64 with SCA 2, 117 with SCA 3, and 68 with SCA 6. Although no specific ocular motor abnormality was pathognomonic to any SCA, significant differences were noted in their occurrence among different disorders. SCA 6 was characterized by frequent occurrence of nystagmus and abnormal pursuit and rarity of slow saccades and ophthalmoparesis and SCA 2 by the frequent occurrence of slow saccades and infrequent nystagmus and dysmetric saccades. SCA 1 and SCA 3 subjects had a more even distribution of eye movement abnormalities.
Prospective data from a large cohort of patients with SCAs 1, 2, 3, and 6 provide statistical validation that the SCAs exhibit distinct eye movement abnormalities that are useful in identifying the genotypes. Many of the abnormalities correlate with greater disease severity measures.
眼球运动异常反映了脊髓小脑共济失调(SCA)的多种神经病理学特征,可能有助于临床上区分不同类型的SCA。我们在一项关于SCA 1、2、3和6型的大型多中心自然史研究中,分析了在基线访视时前瞻性检测到的各种眼球运动异常。
作为脊髓小脑共济失调临床研究联盟(NIH-CRC-SCA)的一部分,前瞻性收集了美国12个中心SCA 1、2、3和6型患者的数据。使用了患者特征、共济失调评定量表、统一亨廷顿病评定量表功能检查和临床分期。记录了包括眼球震颤、扫视和跟踪障碍以及眼肌麻痹在内的眼球运动异常,并检查了影响其发生的因素。
共有301例患者参与了本研究,其中SCA 1型52例,SCA 2型64例,SCA 3型117例,SCA 6型68例。尽管没有任何一种特定的眼球运动异常对任何一种SCA具有诊断意义,但在不同疾病中其发生率存在显著差异。SCA 6型的特征是眼球震颤和异常跟踪频繁发生,慢扫视和眼肌麻痹罕见;SCA 2型的特征是慢扫视频繁发生,眼球震颤和辨距不良性扫视不常见。SCA 1型和SCA 3型受试者的眼球运动异常分布更为均匀。
来自一大群SCA 1、2、3和6型患者的前瞻性数据提供了统计学验证,即SCA表现出不同的眼球运动异常,这有助于识别基因型。许多异常与更高的疾病严重程度指标相关。